Two China-based companies, the Contract Research, Development, and Manufacturing Organization (CRDMO) BioDuro-Sundia and X-Chem, have announced a long-term partnership. X-Chem’s DNA-encoded chemical library (DEL) platform will be integrated into BioDuro-Sundia’s one-stop drug discovery platform to provide higher value to its global clients.
Partnership Details
X-Chem’s DEL platform includes a collection of over 250 billion novel, diverse lead-and drug-like small molecule compounds targeting challenging, high-value therapeutic targets. BioDuro-Sundia will complement this platform by providing protein screening services, ensuring that clients using the DEL platform can verify that potential targets meet the requirements for compound library screening.
X-Chem’s Track Record
X-Chem has reportedly carried out over 100 research projects in the US, Europe, and Japan, identifying more than 1,000 validated hit compounds. This extensive experience and successful track record will enhance the value proposition of BioDuro-Sundia’s global drug discovery services.-Fineline Info & Tech
